Aspartyl (Asparaginyl) ß-Hydroxylase AABH as a serum biomarker for colorectal cancer.

被引：0
|
作者：
Moshiri, Mahmood
Moshiri, Kiarash
Farbod, Yasamin
Moshiri, Arsha
Sekhavati, Mohammad Hadi
机构：
[1] Next Pharma Inc, Richmond Hill, ON, Canada
[2] Poznan Univ Med Sci, Poznan, Poland
[3] Ferdowsi Univ Mashhad, Mashhad, Iran
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
10.1200/JCO.2018.36.5_suppl.86
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
86
引用
收藏
页数：1
相关论文
共 50 条
  • [1] AABH (aspartyl [asparaginyl] β-hydroxylase) as a serum biomarker for breast cancer
    Moshiri, Kiarash
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [2] Aspartyl (asparaginyl) β-hydroxylase (AABH), a serum biomarker for lung cancer
    Moshiri, Kiarash
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [3] AABH (aspartyl (asparaginyl) [beta]-hydroxylase) as a serum biomarker for colorectal cancer diagnosis and prognosis.
    Moshiri, Mahmood
    Moshiri, Arsha
    Moshiri, Kiarash
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [4] Colorectal cancer biomarker, AABH (Aspartyl [Asparaginyl] β- hydroxylase), a companion imaging and treatment strategy
    Moshiri, Mahmood
    Moshiri, Kiarash
    Nazari, Reza
    Pishrochi, Mohammad
    Moshiri, Arsha
    Monhemi, Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [5] Early diagnosis of prostate cancer, AABH (Aspartyl Asparaginyl β-hydroxylase), a predictive biomarker: A serum immunoassay and personalized medicine
    Moshiri, Kiarash
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Aspartyl (Asparaginyl) β-hydroxylase (AABH) as a serum biomarker for prostate cancer, to identify prostate cancer, regardless of PSA level.
    Moshiri, Mahmood
    Moshiri, Arsha
    Pashaei, Hamed
    Moshiri, Kiarash
    Nazari, Reza
    Monhemi, Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [7] Aspartyl (Asparaginyl) β hydroxylase (AABH) as a serum biomarker for prostate cancer to identify prostate cancer, regardless of PSA level.
    Moshiri, Mahmood
    Moshiri, Kiarash
    Moshiri, Arsha
    Monhemi, Hassan
    Sekhavati, Mohammad Hadi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] Development of cancer immunodiagnostics using human aspartyl (asparaginyl) β-hydroxylase (HAAH) as a biomarker.
    Rosen, MA
    Ghanbari, K
    Deutch, AH
    Ghanbari, HA
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3785S - 3785S
  • [9] Improved detection of cancer specific serum exosomal aspartyl (asparaginyl) beta hydroxylase (HAAH)
    Semenuk, Mark A.
    Cifuentes, Anokhi S.
    Ghanbari, Eleanor R.
    Lebowitz, Michael S.
    Ghanbari, Hossein A.
    CANCER RESEARCH, 2017, 77
  • [10] Over-expression of aspartyl (asparaginyl) β-hydroxylase in lung cancer
    Wang, J
    LeGolvan, MP
    Resnick, YB
    de la Monte, SM
    Sabo, E
    Wands, JR
    DeLellis, RA
    Wang, LJ
    LABORATORY INVESTIGATION, 2006, 86 : 319A - 319A
12345